DANONE - Registration document 2015

271 / 364

DANONE REGISTRATION DOCUMENT 2015
Corporate Governance
6.3 Compensation and benefits of corporate officers and governance bodies
271
Total
4/26/2012 4/25/2013 4/29/2014 4/29/2015
2,568,986 1,268,724 1,262,056 1,287,584
1,784,674 447,081 483,685 642,212
7/26/2012 7/26/2012 10/23/2012 7/26/2013 10/23/2013 7/24/2014 10/17/2014 7/23/2015
“3+2” “4+0” “4+0” “4+0” “4+0” “4+0” “4+0” “4+0”
334,406 446,506 3,400 817,993 3,650 776,521 1,850 645,372 4,121,024
7/27/2015 7/27/2016 10/24/2016 7/27/2017 10/24/2017 7/25/2018 10/18/2018 7/24/2019
2 years − − − − − − −
• Growth in sales greater than or equal to the
median sales of the Panel over the 2012, 2013
and 2014 fiscal years;
• Achievement of a consolidated free cash flow
averaging at least €2 billion per year over the
2012 and 2013 fiscal years.
• Average growth in sales
greater than or equal to the
median sales of the Panel over
the 2013, 2014 and 2015 fiscal
years;
• Achievement of a Trading
operating margin level for 2013
and 2014.
• Average growth in sales
greater than or equal to the
median sales of the Panel over
the 2014, 2015 and 2016 fiscal
years;
• Average growth in the Trading
operating margin over the 2014,
2015 and 2016 fiscal years.
• Average growth in sales
greater than or equal to the
median sales of the Panel over
the 2015, 2016 and 2017 fiscal
years;
• Improvement in growth in the
Group's operating margin over
three years (2015, 2016 and
2017) on a like-for-like basis.
• Achievement of the sales criterion determined
by the Board (average growth in 2012, 2013 and
2014 of 5% and median of the Panel of 3.6%).
• The non-achievement of the free cash flow
objective was noted by the Board.
• Sales growth objective from
2013 to 2015: the Board of
Directors will conduct a review
in 2016 to determine whether
this criterion was achieved;
• The non-achievement of the
operating margin objective was
noted by the Board.
A review will be conducted in
2017 by the Board of Directors
to determine whether these
criteria were achieved.
A review will be conducted in
2018 by the Board of Directors
to determine whether these
criteria were achieved.
147,292 238,860 2,268 471,530 1,936 737,346 1,850 − 1,950,995
− − − − − − − 645,372 645,372
− − − − − − 36,000 36,000
(12,148) (18,296) − (41,216) − (53,485) − (5,739) (141,003)
− − − − − − − − −
(7,281) 7,281 − − − − − − −
(127,863) − − − − − − − (467,657)
(47,875) − − − − − − − (47,875)
(13,750) − − − − − − (82,350)
227,845 2,268 430,314 1,936 683,861 1,850 639,633 1,987,707
137,000 − − 137,000 − 122,000 − 36,000 530,000
202,000 40,000 − 239,500 − 217,500 − 109,710 1,006,160
7 3 − 10 − 10 − 12
− − − − − − − 103,790 103,790
− 1,523 5 1,578 9 1,327 4 1,332
(199,262) (225,942) (1,132) (387,679) (1,714) (14,310) − (5,739) (1,106,202)
(d) Of which 109,710 Group performance shares granted to 11 members of the Executive Committee, excluding corporate officers.
(e) Total number of beneficiaries for the "3+2" and "4+0" plans granted by the Board.